Recruitment

Recruitment Status
Completed

Inclusion Criteria

Eligible for PET-CT
Adult over 18
Signed written informed consent
...
Eligible for PET-CT
Adult over 18
Signed written informed consent
Untreated diffuse large B-cell lymphoma
The subject must be covered by a social security system
Untreated stage B or C chronic lymphocytic leukemia

Exclusion Criteria

active infectious disease
Patients concurrently included in an investigational trial
Age under 18
...
active infectious disease
Patients concurrently included in an investigational trial
Age under 18
pregnant women
patients with creatinine clearance < 30 ml/mn
Weight over 120 kg
corticosteroid therapy
immune hemolytic anemia

Summary

Conditions
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
Type
Interventional
Phase
Phase 1
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Diagnostic

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

Eligible for PET-CT
Adult over 18
Signed written informed consent
...
Eligible for PET-CT
Adult over 18
Signed written informed consent
Untreated diffuse large B-cell lymphoma
The subject must be covered by a social security system
Untreated stage B or C chronic lymphocytic leukemia

Exclusion Criteria

active infectious disease
Patients concurrently included in an investigational trial
Age under 18
...
active infectious disease
Patients concurrently included in an investigational trial
Age under 18
pregnant women
patients with creatinine clearance < 30 ml/mn
Weight over 120 kg
corticosteroid therapy
immune hemolytic anemia

Tracking Information

NCT #
NCT02128945
Collaborators
CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France
Investigators
  • Principal Investigator: Sylvain P CHANTEPIE, MD University Hospital, Caen
  • Sylvain P CHANTEPIE, MD University Hospital, Caen